Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Yes it was the surprise raise last November after the investor meeting that started the SP reversal. Then the valentines day massacre as some termed it. In the last year, absent a strong upward trend like in September, good news has had little impact. the closeness to approval may change that...here's to hoping ??
I can only speak for myself, I believe in the potential of SPORT - and hope it is succesful. My theory is the price trend continues until sales commence. This is driving my investing tactics - why I'm on the sidelines. some of the events you listed could change the course, as we saw happen last fall when units were being placed at the 3 centers. But that didn't bolster SP, and the only reasonable explanation is it was not enough without revenue. The market will demand solid sales growth before it pays a premium. I pray I'm wrong, especially for all here who are waiting out long and deep losses. But I believe it would be extraordinary for the SP to buoy otherwise, and seems unlikely. But, what do I know! I will say my theory played out that a large drop would happen after the RS, and I'm happy I was wrong that we'd be at or under $1 by now. I'm not a shorter or a pumper, just cautiously optimistic. In 10 years I think this stock will have made many of us a lot of money.
Thanks BigT!
I think you replied to the wrong post - i didnt say anything about getting in. I was concurring with your point that SP won't buoy until sales are in place.
Agree...recent history has shown "hope" will not float this share price higher. It would be nice but an honest look reflects what you've said, no ticket no taco.
I'm going to sit back with a bottle of busch and some boiled peanuts, and relish watching Intuitive spend themselves broke in legal fees trying to sue the half dozen competitors coming into the market over the next couple years. Ha-ha suck it Intuitive, your time is up, just accept that you will have to compete and you don't get to screw your customers any longer! The witch is dead!
Flex dex is a gimmic and Olympus is a dog.
Spoken like a true sales rep
It would appear so. Don't skewer me, but I don't recall any strong indicators that Mac has ever planned not to. All the speculation about being bought is just that. Good little presser, something to brighten my morning, I doubt it will impact share price, sorry chums.
You too sir! I'm currently out...bought in after the RS and apparent move upward but had to stop loss. I still believe in the product just waiting out the volatility.
The other side of the strategy is selling on the up trend to keep the percentage. So that strategy is not the best fit for a security like TMDI.
A good payout is what we all hope for from Titan!
This is also know as the constant mix strategy : when the stock proce falls, the investor purchases more in order to keep that stock as a certain percentage of their portfolio. This strategy does well with flat but oscillating prices, and does poorly with trending prices.
I bought CFMS at 5 and sold at 8 shortly therafter, fortunately. Sorry to hear about your poor timing, really it's just luck! Ive got a couple posotions like that now
I'm right there with you. I want to buy now because I would've salivated over a $0.13 price last fall when we were soaring with the eagles. But there's too much time between now and commercialization during which the price may continue to trend down. This is why institutional investors are still avoiding TMDI - the profit horizon is too far and especially in this bull market, the opportunity cost is too great. Most are not in the business of taking on such high risk. Obviously we all believe this could be a tremendous growth stock. That's at least 2 years off or more likely 5-10...
Take ConforMIS (CFMS) for example. It seems to be a game changing technology: custom total joint replacement. One could rationally imagine astronomical growth. It's day may not have come yet because Millenials and Gen Xers are probably a better target market than Baby boomers. Their market cap has shrunk massively over the last 5 years, SP went from $25 to $1. I still believe they can make it but its got to become more widely adopted. The company has got to make more price concessions to be competitive; the tech is not enough to justify their price premium. The total joint market is well established. We may face a similar challenge...like it or not ISRG has really set the stage and they are the establishment.
Point is, it will take time to establish market share. Until then the market will price out the high risk from the SP. I want to hope we will be at $7 soon and could double my money but I'm not convinced that will occur based on the circunstances. But what do I know - I'm only right about the market 50% of the time.
Good thing no one reads general surgery news!
If you think about it, long term investors are rewarded more if the SP appreciates and/or dividends are paid. But the opposite is also true, longs are hurt more in decline. So in your despair you are asking for some vague payment based on your loyalty...sorry Charles doesn't work that way you accepted the good with the bad. You are correct the only possibility to make a gain is wait it out and hopefully prosper!
You are living in fantasy land, my friend. Any investment carries firm specific risk, and the risk does not necessarily translate to a proportional level of return, especially for risky companies like Titan. This is why people are re-thinking the traditional broad market beta concept of CAPM, and looking at factor based risk diversification (see smart beta). Anyone who rolled the dice on a pre-market OTC company accepted the high stakes and Titan owes them nothing more than their share of any dividends if and when that time comes. This is the reality we all must face, you're only setting yourself up for further disappointment and resentment if you expect anything more.
That was actually a good little article
Ya know...as. simple as it is, I think the lens wash system will be a real selling point. Cars have had them for decades, but no other scope system has this (at least not to my knowledge). Davinci does not. And de-fogging is a time consuming nagging issue all robotic surgeons face. Prety slick.
Also curious what this new generation of instruments will be like?!
After the 6-14 AGM, It's starting to feel like Titan is really going to pull this off.
Great run down, thanks BigT
The economist is total rubbish. Not even worth using as toilet paper. I cancelled my subscription because they are fools and liars - wrong about almost everything yet still arrogant in their folly. In the 2016 presidential race they had a cover story about dishonesty in the election. 100% about Trump... not a single mention of Hillary's copious lies through her public life, especially the more recent incidences of benghazi and servergate. Absolutely absurd. So I am not surprised they omitted Titan and would not expect an honest or real assessment of the field from the economist.
Thanks, I get it now! More great moves by Big Mac. Progress one step at a time.
Dom - what in that article points to an investment in Titan? It's talking about minimally invasive aesthetics (plastics).
Thank you my brother...man I rode FIZZ up a couple years back it was great. But that's another discussion for board.
Typically a price target is what the analyst believes is the value of the stock, so he's saying it's undervalued and you should expect it to trade at $11 because "the market is efficient"...thing is, is anyone listening to him?
Answered my own question
https://www.streetinsider.com/dr/news.php?id=14352426
Do you have a link to anything showing this? Do you use them?
My head is spinning - great day, thank you Big Mac. Good times ahead.
Seems you may need a gelport in either scenario :X i don't know the resilience of the umbilicus hole but -unqualified opinion- seems you wouldnt want to stretch it, if the specimen wouldn't naturally fit coming out. Can anyone clinical elaborate?
25mm on the umbilicus - no visible scars. Get it right or pay the price!
TXRC may be a short term gem but it should implode as sales and EBITDA growth continue in a negative trend. Probably not a long term gem. More of a passing curiosity. The street rated them a sell as of 6/21. I argue senhance is an excercise in mediocrity and wilk be long forgotten in 5-10 years.
I agree with your assessment.
I just converted the 8.54 CAD TMD price to 6.43 USD!
Now we never have to discuss the R/S again and soon the uplist will be behind us. Skeptics, you have to admit BigMac daddy is delivering on his promises. I'm encouraged abut the prospects for the next steps. He is steering this ship to treasure!
Im showing that as well now on TD
Nothing still on TD
Same nothin on TD yet. Wow the guy making the ticker symbols really had fun with TITDX. haha I'd think we will get attention now for being the dirtiest ticker, if for nothing else.
Haha thanks for the laugh. You know dd stands for DUE diligence, not doo diligence.
Exactly - because senhance does not peak enough interest to become a priority. XIs ARE flying off the shelf...Trixie has not put a dent in intuitive's armor. Senhance seems to be a curiosity, not an industry leading and in demand technology.
Compare with SPORT...when it's commercialized it faces competition from the SP, but at least it plays in a new frontier of surgery and delivers a novel approach.
No one knows this better than me - been in healthcare supply chain going on 12 years...physicians drive large capital purchases like this and yes budgeting takes many years sometimes before a purchase can be made. But if this was a priority, surgeons would be pushing their other requests down the priority list to get one of these. Perhaps the 3 year from sales mark is a better measure. but consider that 5 units sold, if each unit goes to a separate hospital, equals 0.09% of all hospitals making a purchase (AHA 2018 = 5534 hospitals). 1/10 of 1 percent does not strike me as material.